Posters presentation with Novadiscovery and Calvagone at the PAGE Meeting

ENYO Pharma is pleased to collaborate with Novadiscovery and Calvagone which will present the first in silico liver disease model and the pharmackinetics-pharmacodynamics analysis respectivelly of EYP001 treatment effect on Hepatitis B virus (HBV) infected patients at the PAGE Meeting, May 29th – June 1st, 2018 in Switzerland.
Poster with Novadiscovery
Poster with Calvagone

Read next in 'Latest news'